Duavive
oestrogens conjugated
bazedoxifene
Postmenopause
Date of authorisation:
Revision: 15
Last updated:
MedicineHumanAuthorised
EMEA-001356-PIP02-12-M04 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Gastroentology-Hepatology
PIP number: P/0134/2021
Route(s) of administration: Oral use
Pharmaceutical form(s):
Powder for oral suspension
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
Conbriza
bazedoxifene
Osteoporosis, Postmenopausal
Date of authorisation:
Revision: 15
Last updated:
MedicineHumanAuthorised
EMEA-000998-PIP01-10 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism
PIP number: P/155/2010
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Brilence
bazedoxifene
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application